BMI percentile trajectories and liver enzyme changes in children with metabolic dysfunction–associated steatotic liver disease: A longitudinal cohort study
Journal of Pediatric Gastroenterology and Nutrition · 18.11.2026
DOI: 10.1002/jpn3.70672 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, online erschienen am 18.11.2026. Verfasst von Nhat Quang N. Thai und 13 weiteren Autor:innen. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Objectives
The incidence of pediatric obesity and metabolic dysfunction–associated steatotic liver disease (MASLD) are rapidly rising. However, the impact of dynamic body mass index (BMI) changes on liver chemistries remains understudied. We investigated the association between longitudinal changes in BMI percentile and changes in liver chemistries among children with MASLD.
Methods
In this multicenter study, 1169 children with biopsy‐confirmed MASLD enrolled in the Nonalcoholic Steatohepatitis Clinical Research Network were followed for a mean of 4.0 years. BMI percentiles were calculated using the lambda‐mu‐sigma method with an extended metric to capture nuances at extreme values. Generalized linear mixed‐effects models with random effects for patients and clinics were applied, and inverse probability treatment weighting adjusted for demographics and baseline histologic features. Sensitivity analyses stratified by sex and ethnicity assessed robustness.
Results
Participants (mean age 13 years; 72% Hispanic) with higher BMI percentiles exhibited elevated blood pressures, increased insulin levels, and a lower frequency of the patatin‐like phospholipase domain‐containing protein 3 ( PNPLA3) GG variant. Each 5‐unit increase in BMI percentile was independently associated with a 23% increase in alanine aminotransferase (1.23; 95% confidence interval [CI], 1.17–1.30), a 13% increase in aspartate aminotransferase (1.13; 95% CI, 1.09–1.17), and a 12% increase in γ‑glutamyl transferase (1.12; 95% CI, 1.08–1.16).
Conclusions
Longitudinal increases in BMI percentile are independently associated with worse liver chemistry in pediatric MASLD. Routine monitoring of BMI trajectories, alongside early weight management strategies, may be critical to mitigating disease progression. Trial Registration ClinicalTrials.gov: NCT01061684, NCT04454463.
Förderung
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institutes of Health
Zitieren
APA
Thai, N. Q. N., Klapp, J., Chun, L. F., Newton, K. P., Wilson, L. A., Belt, P. H., Mouzaki, M., Xanthakos, S. A., Behling, C. A., Salem, R. M., Bandoli, G., Alcaraz, J., Crespo, N., & Schwimmer, J. B. (2026). BMI percentile trajectories and liver enzyme changes in children with metabolic dysfunction–associated steatotic liver disease: A longitudinal cohort study. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1002/jpn3.70672
Vancouver
Thai NQN, Klapp J, Chun LF, Newton KP, Wilson LA, Belt PH, et al. BMI percentile trajectories and liver enzyme changes in children with metabolic dysfunction–associated steatotic liver disease: A longitudinal cohort study. Journal of Pediatric Gastroenterology and Nutrition. 2026. doi:10.1002/jpn3.70672
BibTeX
@article{Thai2026,
author = {Thai, Nhat Quang N. and Klapp, Jamie and Chun, Lauren F. and Newton, Kimberly P. and Wilson, Laura A. and Belt, Patricia H. and Mouzaki, Marialena and Xanthakos, Stavra A. and Behling, Cynthia A. and Salem, Rany M. and Bandoli, Gretchen and Alcaraz, John and Crespo, Noe and Schwimmer, Jeffrey B.},
title = {BMI percentile trajectories and liver enzyme changes in children with metabolic dysfunction–associated steatotic liver disease: A longitudinal cohort study},
journal = {Journal of Pediatric Gastroenterology and Nutrition},
year = {2026},
doi = {10.1002/jpn3.70672}
}
EUVIMED